nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Approach Toward Germline Predisposition Syndromes in Patients with Hematologic Malignancies
|
Atluri, Himachandana |
|
|
17 |
6 |
p. 275-285 |
artikel |
2 |
Bispecific Antibodies for the Treatment of Multiple Myeloma
|
Goldsmith, Scott R. |
|
|
17 |
6 |
p. 286-297 |
artikel |
3 |
Circulating Tumor DNA in Lymphoma
|
Thiruvengadam, Swetha Kambhampati |
|
|
17 |
6 |
p. 298-305 |
artikel |
4 |
CML Resistant to 2nd-Generation TKIs: Mechanisms, Next Steps, and New Directions
|
Scalzulli, Emilia |
|
|
17 |
6 |
p. 198-205 |
artikel |
5 |
Defining Higher-Risk Chronic Myeloid Leukemia: Risk Scores, Genomic Landscape, and Prognostication
|
Shahrin, Nur Hezrin |
|
|
17 |
6 |
p. 171-180 |
artikel |
6 |
Molecular Pathogenesis of Myeloproliferative Neoplasms
|
Rolles, Benjamin |
|
|
17 |
6 |
p. 319-329 |
artikel |
7 |
Pediatric Germline Predisposition to Myeloid Neoplasms
|
Thompson, Christineil |
|
|
17 |
6 |
p. 266-274 |
artikel |
8 |
Precision Medicine in Myeloid Malignancies: Hype or Hope?
|
Upadhyay Banskota, Shristi |
|
|
17 |
6 |
p. 217-227 |
artikel |
9 |
Prevalence and Determinants of Return to Work as a Patient-Centered Outcome in Survivors of Hematopoietic Cell Transplantation
|
Bhatt, Neel S. |
|
|
17 |
6 |
p. 228-242 |
artikel |
10 |
Progress and Challenges in Survivorship After Acute Myeloid Leukemia in Adults
|
Granroth, Ginna |
|
|
17 |
6 |
p. 243-253 |
artikel |
11 |
Role of Germline Predisposition to Therapy-Related Myeloid Neoplasms
|
Baranwal, Anmol |
|
|
17 |
6 |
p. 254-265 |
artikel |
12 |
Therapy Resistance and Disease Progression in CML: Mechanistic Links and Therapeutic Strategies
|
Ng, John Joson |
|
|
17 |
6 |
p. 181-197 |
artikel |
13 |
The Role of Belantamab Mafodotin, Selinexor, and Melflufen in Multiple Myeloma
|
McCurdy, Arleigh |
|
|
17 |
6 |
p. 306-318 |
artikel |
14 |
Value in Myeloma Care: Myth or Reality
|
Ouchveridze, Evguenia |
|
|
17 |
6 |
p. 206-216 |
artikel |